NEW YORK, April 12 - Zyomyx and Axon Instruments have agreed to jointly develop scanning instrumentation for acquiring and analyzing data from Zyomyx's protein biochips, the companies said Thursday.

Zyomyx, which has said it plans to release a beta version of its chip later this year, will work with Axon to build several generations of scanning products and evaluate fluorescence and non-fluorescence platforms. The companies did not disclose financial details.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.